Metabolic syndrome and coronary artery bypass graft surgery

Metabolic syndrome (MS) is a constellation of disorders that increases the risk for coronary heart disease. This study was conducted to examine the incidence of metabolic syndrome in coronary artery bypass graft (CABG) patients and to determine if metabolic syndrome affects clinical outcomes in the perioperative setting.